RGT anti-a bcln 150ML mncln ABO GRP BB

Ended Awarded

Contract number
SPE2D326F301R
Awardee
Awarding agency
Obligated
$1,018

Award facts

Contract value 100% obligated
$1,018.08 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

About this award

Medical Supply Chain, a Defense Department funding agency, awarded a delivery order with a $1,018.08 ceiling to Quidelortho Sales Company, LLC on July 27, 2026. The order is a firm fixed price action with no set-aside, and the prime is HUBZone-certified. Place of performance is Raritan, NJ 08869, and the ultimate completion date is July 28, 2026. The government description is "RGT ANTI-A BCLN 150ML MNCLN ABO GRP BB," a 150 mL monoclonal anti-A blood bank reagent.

Quick answers

Who was awarded contract SPE2D326F301R?

SPE2D326F301R was awarded to Quidelortho Sales Company, LLC by Medical Supply Chain (Troop Support) on July 27, 2026.

How much is contract SPE2D326F301R worth?

The government has obligated $1,018 on SPE2D326F301R.

Is contract SPE2D326F301R an order under another contract?

Yes. SPE2D326F301R is a delivery order under SPE2D018D0005, an indefinite delivery contract.

Was contract SPE2D326F301R competed?

The extent of competition for SPE2D326F301R was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award